Publication | Closed Access

Comparison of acute kidney injury risk associated with vancomycin and concomitant piperacillin/tazobactam or cefepime in the intensive care unit

Critical Care ManagementCritical Care MedicineIntensive Care UnitClinical InjuryAntibioticsAcute CarePatient SafetyAntimicrobial PharmacokineticsAcute Kidney InjuryMedicineNephrologyEmergency MedicineConcomitant Piperacillin/tazobactam